Business Description
Atlassian Corporation, operating globally via its subsidiaries, specializes in creating, distributing, and supporting a diverse range of software solutions. Its extensive product suite features Jira Software and Jira Work Management, comprehensive project management platforms enabling technical and business teams to efficiently plan, organize, monitor, and execute tasks. Confluence serves as a collaborative workspace, centralizing knowledge to advance team efforts, while Trello provides a flexible tool for teams to structure and manage dynamic, rapidly evolving projects. Additionally, Atlassian provides Jira Service Management, an adaptable service desk solution empowering IT, legal, HR, and other service teams to deliver and oversee exceptional service experiences. Another key offering is Jira Align, an enterprise agility platform crafted to assist businesses in navigating dynamic market conditions by prioritizing value generation. Furthermore, its offerings include Bitbucket, an enterprise-grade Git repository management system facilitating professional development teams in collaborating on, managing, and deploying high-quality code. Atlassian Access provides robust, enterprise-wide security and centralized administration, enhancing data governance across its entire suite of cloud products. The portfolio also contains Jira Product, a dedicated tool for prioritizing and mapping out product roadmaps. The company's diverse portfolio extends to Atlas, a teamwork directory; Bamboo, a continuous delivery pipeline; Crowd for single sign-on capabilities; Crucible for collaborative code reviews; Fisheye, a tool to search, track, and visualize code changes; and Compass, a developer experience platform. Other notable products encompass Opsgenie, for on-call and alert management; Sourcetree, a free Git client for Windows and Mac; Statuspage, for real-time status communication to users; and Beacon, an intelligent threat detection system. Established in 2002, Atlassian Corporation maintains its headquarters in Sydney, Australia.
Business History
Price Overview
Last updated: Jun 27, 2026 9:05am (just now)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -0.98
Total Equity: $1.35B
Shares: 261,787,000
Total Debt: $987.68M
Cash: $2.51B
EBITDA: $24.03M
Total Debt: $987.68M
Cash: $2.51B
Revenue: $5.22B
Shares: 261,787,000
Revenue: $5.22B
Revenue: $5.22B
Revenue: $5.22B
Total Equity: $1.35B
Tax Rate: -159.6%
Equity: $1.35B
Total Debt: $987.68M
Cash: $2.51B
Current Liabilities: $3.18B
Long-Term Debt: $987.68M
Total Debt: $987.68M
Total Equity: $1.35B
Shares: 261,787,000
Shares: 261,787,000
CapEx: -$44.85M
Shares: 261,787,000
Stock Price: $78.74
Net Income: -$256.69M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 25, 2026 11:34am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.8B | $3.5B | $4.4B | $5.2B |
| Cost of Revenue | $346.7M | $452.9M | $633.8M | $803.5M | $894.9M |
| Gross Profit | $1.7B | $2.3B | $2.9B | $3.6B | $4.3B |
| Operating Expenses | $1.7B | $2.3B | $3.2B | $3.7B | $4.5B |
| Operating Income | $67.6M | $70.1M | -$345.2M | -$117.1M | -$130.4M |
| Net Income | -$696.3M | -$519.5M | -$486.8M | -$300.5M | -$256.7M |
| EBITDA | -$419.1M | -$377.7M | -$220.1M | $27.4M | $24.0M |
| EPS | $-2.79 | $-2.05 | $-1.90 | $-1.16 | $-0.98 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 25, 2026 11:34am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $919.2M | $1.4B | $2.1B | $2.2B | $2.5B |
| Total Current Assets | $1.6B | $1.9B | $2.7B | $3.1B | $3.9B |
| Total Assets | $2.9B | $3.3B | $4.1B | $5.2B | $6.0B |
| Current Liabilities | $2.3B | $1.6B | $2.0B | $2.6B | $3.2B |
| Long-Term Debt | $0 | $999.4M | $962.1M | $985.9M | $987.7M |
| Total Liabilities | $2.7B | $3.0B | $3.5B | $4.2B | $4.7B |
| Total Equity | $294.9M | $327.4M | $654.7M | $1.0B | $1.3B |
| Retained Earnings | -$1.8B | -$1.9B | -$2.5B | -$3.2B | -$4.2B |
Cash Flow (Annual)
Last updated: Jun 25, 2026 11:34am (1d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $790.0M | $821.0M | $868.1M | $1.4B | $1.5B |
| Capital Expenditure | -$33.3M | -$70.6M | -$25.8M | -$33.1M | -$44.9M |
| Free Cash Flow | $756.6M | $750.5M | $842.3M | $1.4B | $1.4B |
| Acquisitions (net) | -$91.8M | -$12.4M | -$5.8M | -$847.8M | -$14.2M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | -$150.0M | -$395.3M | -$779.4M |
| Net Change in Cash | -$560.7M | $466.0M | $717.2M | $74.2M | $335.6M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 11:15pm (9h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$7.4B $7.0B – $7.6B
|
$8.7B $8.6B – $8.7B
|
$10.1B $9.7B – $10.3B
|
$11.3B $10.9B – $11.6B
|
| EBITDA |
$1.7B $1.6B – $1.7B
|
$2.0B $2.0B – $2.0B
|
$2.3B $2.2B – $2.3B
|
$2.6B $2.5B – $2.6B
|
| Net Income |
$1.6B $1.5B – $1.8B
|
$2.3B $1.2B – $3.5B
|
$2.3B $2.1B – $2.3B
|
$2.8B $2.6B – $2.8B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 25, 2026 11:34am (1d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +34.2% | +26.1% | +23.3% | +19.7% |
| Gross Profit Growth | +34.9% | +23.4% | +22.6% | +21.5% |
| Operating Income Growth | +3.6% | -592.6% | +66.1% | -11.4% |
| Net Income Growth | +25.4% | +6.3% | +38.3% | +14.6% |
| EBITDA Growth | +9.9% | +41.7% | +112.5% | -12.3% |
Insider Trading (Recent)
All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-10 | DUFFY BRIAN | S-Sale | 1,813.00 | $92.79 | $168,228 |
| 2026-06-11 | DUFFY BRIAN | S-Sale | 1,432.00 | $88.79 | $127,147 |
| 2026-06-12 | DUFFY BRIAN | S-Sale | 3,000.00 | $89.71 | $269,130 |
| 2026-06-08 | DUFFY BRIAN | S-Sale | 1,451.00 | $98.03 | $142,242 |
| 2026-06-09 | DUFFY BRIAN | S-Sale | 1,454.00 | $95.35 | $138,639 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 389.00 | $90.29 | $35,124 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 5,440.00 | $86.59 | $471,027 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 26.00 | $94.16 | $2,448 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 659.00 | $89.23 | $58,799 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 152.00 | $93.39 | $14,196 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 273.00 | $88.24 | $24,088 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 358.00 | $92.53 | $33,125 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 977.00 | $87.17 | $85,168 |
| 2026-05-19 | CHUONG JAMES | S-Sale | 564.00 | $91.38 | $51,538 |
| 2026-05-19 | LIU GENE | S-Sale | 3.00 | $92.53 | $278 |
| 2026-05-19 | LIU GENE | S-Sale | 1.00 | $93.39 | $93 |
| 2026-05-19 | LIU GENE | S-Sale | 7.00 | $87.17 | $610 |
| 2026-05-19 | LIU GENE | S-Sale | 3.00 | $90.29 | $271 |
| 2026-05-19 | LIU GENE | S-Sale | 42.00 | $86.59 | $3,637 |
| 2026-05-19 | LIU GENE | S-Sale | 5.00 | $89.23 | $446 |
Narrative Economics
market-narrative step).